Parenting skills program aims to boost chemo adherence in kids with leukemia
NCT ID NCT06074666
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a behavioral program called CareMeds that teaches parents skills to help their young children (ages 3-9) with acute lymphoblastic leukemia take oral chemotherapy at home. Researchers will enroll 100 families across two cities to see if the program is feasible and acceptable. They will measure parenting behaviors and how consistently children take their medication using electronic bottle caps.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
CareMeds behavioral parenting intervention
What this could lead to
If successful, this program could help parents better manage their child's oral chemotherapy, potentially improving treatment outcomes for pediatric leukemia.
What could go wrong
This is an early feasibility study with only 100 participants, so results may not apply to all families. The intervention is behavioral, not a drug, so it won't directly treat the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Roswell Park Comprehensive Cancer Center
RECRUITINGBuffalo, New York, 14263, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••